Department of Health and Social Care written question – answered at on 16 January 2023.
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential impact of changes to the Voluntary Scheme for Branded Medicines Pricing Access rebate on (a) investment in clinical trials and (b) the UK's market for launching innovative treatments.
To ask the Secretary of State for Health and Social Care, with reference para 1.11 of the 2019 Voluntary Scheme for Branded Medicines Pricing and Access - Chapters and Glossary, published December 2018, whether he has made an assessment of that schemes progress against its objectives; and if he will make a statement.
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the relationship between the Voluntary Scheme for Branded Medicines Pricing Access and the delivery of the Life Sciences Vision; and if he will make a statement.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.